Breaking News:Dangerous Delays: What Washington State (Re)Teaches Us About Cash and Cannabis Store Robberies [REPORT]

Methamphetamine

RSS Feed for this category

Chronicle AM: Senate Extends Protections for State MMJ Programs, PA Pot Poll, More... (11/1/19)

New South Wales ponders drug decriminalization, the Senate extends protections for state medical marijuana programs, and more.

Ice (methamphetamine). Australia's New South Wales is pondering drug decriminalization as it looks at meth use. (CC)
Marijuana Policy

Pennsylvania Poll Has Strong Support for Legalization, Less for State-Run Stores. A new Franklin & Marshall College poll has support for marijuana legalization at 58%, but 40% are much less likely to support it if pot would be sold in state liquor stores.

Medical Marijuana

Senate Approves Bill Protecting Medical Marijuana States from Federal Intervention. The Senate on Thursday approved a "minibus" appropriations bill covering several agencies that extends a provision protecting state medical marijuana programs from federal interference. The House has passed a version of the bill with even broader protections for all state marijuana programs, so the question now is whether the House language will be adopted in the final bill.

International

Australia's New South Wales Ponders Drug Decriminalization. The New South Wales Special Commission of Inquiry into Ice (methamphetamine) will release its recommendations next week, but there are already indications that the commission will lean in the direction of harm reduction approaches, as well as drug decriminalization. The commission will reportedly also recommend pill testing at a fixed site and possibly music festivals and expanding the use of safe injection sites.

Does This State Have the Worst Drug Policies in America? [FEATURE]

With endless miles of farmland shading into ever higher and drier terrain as one moves west, crossing the Missouri River and then on to the Badlands and the Black Hills, South Dakota has a certain austere beauty. Not so in its approach to drugs. When it comes to drug policy, it is one of the ugliest places in the country.

South Dakota's Badlands. The state is a pretty bad land for drug users, too. (Creative Commons)
The staunchly conservative state holds the dubious distinction of being the only state to twice defeat a medical marijuana initiative. (Activists are giving it another shot this year -- and a more wishful legalization initiative, too.) And it is being sued by the state ACLU over the forced drug testing of toddlers and arrestees alike.

South Dakota also boasts the nation's only law making ingestion -- not possession -- of a controlled substance a felony, which helps explains the reflex resort to drug testing arrestees: A positive drug test becomes a prosecutable offense. While 10 other states have ingestion laws on the books, none of them makes it a felony.

And now, a new report from the Prison Policy Initiative finds that "South Dakota jails more people per capita than any other state," that almost "half of all arrests are drug or alcohol related, compared to just 29 percent nationally," and that people of color -- in this case, primarily Native Americans -- are disproportionately arrested at a rate far above the national average.

According to the report, South Dakota jailed 2,888 people per 100,000, nearly twice the national average of 1,506, and narrowly edging out Mississippi, which had 2,814 per 100,000. (Other states that jailed more than one out of 50 of their residents were Georgia, Kansas, Kentucky, New Mexico, Oklahoma, and Wisconsin.)

But jail is just the gateway to the incarceration complex, and when it comes to long-term stays behind bars, South Dakota displays the same sort of worrying numbers. According to the ACLU of South Dakota, the state's prison population has increased more than five-fold since 1980, a decade after the drug war began. And despite 2013 reforms designed to reduce the prison population, it stubbornly stays near an all-time high reached in 2017.

In fact, new prison admissions spiked upward by 49 percent between 2015 and 2018. These numbers are largely attributable to drug prosecutions, with nearly one in three prisoners doing time for drugs in 2019, up from one in four in 2014.

As the ACLU noted, "This increase was driven almost entirely by a rise in the number of people whose most serious offense was unauthorized ingestion of a controlled substance."

That's right -- South Dakota is spending millions of dollars to incarcerate people not for drug dealing, not even for drug possession, but for having used drugs and still having traces of them in their system.

And it's doing so in an alarmingly racially disproportionate manner. Native Americans make up only 7 percent of the state's population but constitute nearly one-third (31 percent) of the state prison population. Similarly, the state has a tiny African American population (2 percent), but black South Dakotans made up 8 percent of the prison population. The imprisonment rate for both African Americans and Native Americans was seven times that of the state's overwhelmingly white population. For the state's Latino population, the imprisonment rate was twice that of whites.

In a press release last month, the state ACLU reported that it's just as bad in the state's jails, with Native Americans making up roughly half of all jail admissions and accounting for the majority of all drug- and alcohol-related arrests in the state. The group noted that "Native Americans between ages 15 and 64 are incarcerated at 10 times the rate of white people in South Dakota."

"It's time to come to terms with the significant racial disparities that are so ingrained in our criminal legal system," said Libby Skarin, ACLU of South Dakota policy director. "This is not something that can be mitigated by solely reducing the number of arrests in South Dakota. Our elected officials need to acknowledge the realities of these racial disparities and commit to tackling them head-on."

State leaders grasp that there is a problem here. The state legislature has set up an interim study group to examine the state's approach to drug offenses, which met for the first time in August. The group includes legislators, law enforcement, court administrators, the South Dakota attorney general and the secretary of the Department of Corrections, but not public health officials or actual drug users.

The panel heard even more disturbing numbers about drug prosecutions. There were 2,104 people convicted of drug possession statewide so far this year, a more than four-fold increase from 2009, even though drug use levels have remained relatively stable over that period. That is leading panel members to wonder about the role of local prosecutors in generating such large increases in prosecutions.

"Though drug use is undoubtedly a serious issue, we can't incarcerate our way out of addiction," said the ACLU's Skarin. "The enormous amount of money South Dakota spends on jailing people for drug-related offenses is disproportionate and causes more harm than good to individuals struggling with addiction, their families and their communities."

It is for this reason that the ACLU says it is supporting initiatives such as "reclassifying ingestion as a misdemeanor."

Skarin explained, "Reclassifying ingestion as a misdemeanor and investing the resulting savings of state funds in diversion and treatment programs designed to combat addiction would go a long way in helping to solve the underlying problems leading to drug abuse."

Pennington County (Rapid City) public defender Eric Whitcher is on the same page as the state ACLU. He told the interim panel that 73 of his last 100 drug possession cases involved only trace or immeasurable amounts of drugs and that if such cases were not charged as felonies, his office could operate with significantly fewer felony prosecutors.

"We are an outlier," said Whitcher, speaking about South Dakota. "We are creating more felonies for the same conduct than our neighboring states. What impact does that have on their lives?"

Dropping ingestion from a felony to a misdemeanor would be a step in the right direction, but it's an awfully small step. South Dakota has a long, long way to go to get on the right side of drug policy, and no natural beauty can hide that.

Why Are Meth- and Cocaine-Related Overdose Deaths on the Increase? [FEATURE]

August 31 is International Overdose Awareness Day, overdoseday.com
Last month, the Centers for Disease Control and Prevention (CDC) released provisional data indicating that the country's overdose crisis peaked in late 2017 and actually declined by 5.1 percent between then and late 2018. While that is long-awaited good news, it's not great news: The annual number of drug overdose deaths was still more than 68,000, and that number is still more than a third higher than in 2014, when the overdose epidemic was already well underway.

The fever may have broken, but the patient is still in critical condition. And there is one bit of data in the CDC report that is definitely not good news: While overall overdose deaths finally began to decline, overdose deaths involving stimulants were on the increase. For cocaine, the death toll started rising in about 2012; for psychostimulants (overwhelmingly methamphetamine), the climb began a couple of years earlier.

But the new data show a dramatic uptick in overdose deaths with stimulant involvement last year. Fatal overdoses where cocaine was mentioned were up 34 percent and those where methamphetamine was involved were up 37 percent. That's more than 14,000 people dying with cocaine in their systems and more than 10,000 dying with meth in their systems.

What is driving this spike in stimulant-involved overdose deaths? Some of it can be attributed to rising use levels for cocaine and meth, which can in turn be linked to increased supplies. Meth seizures were up dramatically last year and recent DEA reports suggest that cocaine availability has increased steadily since 2012, particularly in the south and east coast of the US. The UN Office of Drugs and Crime suggests that cocaine production and manufacture are at the highest rates ever recorded.

"There is some research to suggest that we are seeing slightly higher rates of recent cocaine and methamphetamine use compared to rates of use just a few years ago," said Sheila Vakharia, PhD, a researcher with the Drug Policy Alliance (DPA). "But increased rates of use do not always mean increased rates of addiction or overdose. Death rates are influenced by a variety of factors, including age of the user, the amount used, and other substances used, among other things."

They are also influenced by race, gender, and geographic location. A recent study looking at data from 2012 to 2015 and examining race and gender trends by drug found that white men had the highest rates of methamphetamine-involved overdose deaths more generally, while black men had highest rates of cocaine-involved overdose deaths. These racial differences persisted for women of each race as well, although their overdose rates were lower than the men in their racial groups.

"Methamphetamine-involved deaths are high on the West Coast and Midwest, while cocaine-involved deaths are high on the East Coast. We are actually seeing that in some Western states that methamphetamine is either the top drug involved in overdose deaths or among the top drugs included in overdose deaths," Vakharia noted.

"Based on the latest CDC data, Nevada’s overdose crisis has been driven by prescription opioids and methamphetamine for the past several years- in fact, methamphetamine has been the #1 drug involved in overdoses there since November 2016. Similarly, in November 2016, Oregon saw methamphetamine become the top drug involved in overdose deaths," she specified.

"Meanwhile, the East Coast is seeing the involvement of cocaine in overdoses increase as well. While no eastern state has cocaine driving their overdose crisis, places like DC are seeing fentanyl as the top driver of deaths followed by cocaine. Last year, while fentanyl contributed to the majority of overdose deaths, there were more cocaine-involved deaths than heroin or prescription opioids," Vakharia added.

It appears that it is not rising simulant use rates but the use of multiple substances that is largely driving the overall stimulant death toll upwards. A CDC report from May suggests that, from 2003 to 2017, almost three-quarters of cocaine-involved deaths involved an opioid while half of all methamphetamine involved deaths involved an opioid.

"Those CDC numbers are based on autopsy reports," said Daniel Raymond, deputy director of planning and policy for the Harm Reduction Coalition (HRC). "In a lot of cases, there are multiple drugs involved, and just because an overdose involves a stimulant, it doesn't mean it was caused by stimulants."

Overdose deaths caused by stimulants look different from those caused by opioids, Raymond noted: "Fatal stimulant overdoses come from strokes, seizures, heart attacks, and potentially overheating," he said. "It's not like an opioid overdose with respiratory depression," he said.

"Some of this may be more a reflection that we still have lots of people dying from opioid-related overdoses, and it's just that more of them are also taking meth or cocaine, but the primary cause of death is the respiratory depression associated with opioid overdoses. In a lot of the cocaine deaths, medical examiners are finding both cocaine and opioids."

"We are seeing that toxicology reports of people who died with stimulants in their systems also had fentanyl or other opioids in their system," DPA's Vakharia concurred. She then listed a number of possible explanations:

  1. "This is accidental. Cross-contamination of a stimulant with an opioid like fentanyl could have been accidental and occurred during transport or packaging, and opioid-naïve stimulant users were accidentally exposed to opioid-contaminated stimulants."
  2. "This is due to co-use of opioids and stimulants in the form of speedballs (with cocaine) or goofballs (with methamphetamine), where both are used together for the desired effect of immediately stimulating high, followed by the euphoria of the opioid."
  3. "Stimulants are being willfully adulterated with opioids by suppliers/sellers, and stimulant users naïve to opioids are overdosing because they have no tolerance. (We at DPA dispute this theory, because it makes little sense why a seller would want to kill off a customer.)
  4. "Someone might have used a stimulant and opioids at different times within the past few days, but their toxicology could be showing the recency of use."

What Is to Be Done?

The Drug Policy Alliance and the Harm Reduction Coalition have both released reports on the rise in stimulant-involved overdose deaths, Stimulant Use: Harm Reduction, Treatment, and Future Directions from the former and Cocaine, Speed, and "Overdose": What Should We Be Doing? from the latter. Raymond and Vakharia took a few minutes to address those topics, too.

"There is no naloxone for stimulant overdose," Raymond pointed out. To reduce those overdoses "is about developing harm reduction strategies and outreach specifically targeting stimulant users," he said. "We spend so much time focusing on the opioid overdose crisis that our messages are oriented toward that. If we want to start a conversation, we need to not just tack it onto the opioid messaging. Even if you're not an opioid user, we want to talk about symptoms and warning signs."

HRC has moved in that direction, said Raymond. "We did some work on stimulant overdoses, we talked to a lot of people who used stimulants, we put out a guide -- Stimulant "Overamping”"Basics -- and went with the terms people used. Using 'overamping' opened a space for conversation for people who didn't identify as heroin users. If you talk overamping instead of overdosing, stimulant users have had that experience of using too much. Part of it is really just listening to the people who use the drugs. In harm reduction, we learn from the people we work with."

"People who use stimulants need access to sterile equipment beyond syringes, since many stimulant users smoke, so we are talking about sterile smoking equipment like pipes and filters," Vakharia said. "We need to teach users how to stay safe while using -- make sure to take breaks for hydration and to eat, get enough rest. It is easy to lose track of time when you've been up for days and when you have no appetite. This also puts undue stress on your heart and can exacerbate health issues," she noted.

"For many people, we should also talk about distributing safer sex supplies, because many people engage in risky sexual practices while they are using," Vakharia continued. "We also need to educate users on the risks associated with mixing different classes of drugs and the impact it can have on your body, knowing your limits, keeping naloxone on hand in case you are using opioids too, and not using alone."

It's not just harm reduction that's needed, though. Other policy prescriptions could help reduce the toll.

"Medicaid expansion and policies to increase access to basic health care and mental health care, as well as substance use treatment can greatly improve the health and well-being of people who use all drugs," Vakharia said. "And whether opioids are a person's primary drug or not, expanding access to naloxone helps anyone who is using them. Similarly, expanding Good Samaritan laws that reduce barriers to calling 911 can only help."

And then there's not treating drug uses like criminals.

"Decriminalizing drugs and paraphernalia would be a huge step forward," said Vakharia. "We know that contact with the criminal justice system increases harms and also presents barriers to going into recovery, which impacts job prospects, the ability to find work, and things like that."

"Drug decriminalization is crucial," said Raymond. "Criminalization just makes everything worse. It makes people more fearful of seeking help, and ends up locking so many people up in ways such that when they leave jail or prison, they're even more vulnerable. All of our work in harm reduction takes place in this context of mass criminalization. That keeps us swimming against the tide."

This article was produced by Drug Reporter, a project of the Independent Media Institute.

The Drug Policy Alliance is a funder of both Drug Reporter and Drug War Chronicle.

Chronicle AM: VA Pot Arrests at Record High, Brazil Guts Drug Council, Mark Kleiman RIP, More... (7/22/19)

A leading academic voice on drug and criminal justice policy has left us, skyhigh Virginia pot arrests prompt calls for reform, Brazil's rightist government moves to silence critical voices on drug policy, and more. 

Drug reform and criminal justice scholar Mark Kleiman has died at age 68. (Creative Commons)
Marijuana Policy

Virginia Marijuana Arrests at Highest Level in 20 Years. Nearly 29,000 people were arrested on marijuana charges in the state last year, the vast majority for simple possession. That figure is three times the level of 1999 and accounts for nearly 60% of all drug arrests in the state. The spike is leading to calls for decriminalization by some lawmakers, as well as state Attorney General Mark Herring (D), who last month when became the state’s highest official to call for legalizing marijuana for recreational use.

Medical Marijuana

Mississippi Medical Marijuana Initiative Still Looking for Signatures. The Medical Marijuana 2020 campaign is still hunting signatures to qualify its medical marijuana initiative for the November 2020 ballot. The campaign needs to turn in some 86,000 valid voter signatures by October and says it has already gathered more than 100,00 raw signatures.

Utah Regulators Announce Choice of Applicants to Grow Medical Marijuana. The state Department of Agriculture and Food announced Friday it has chosen eight applicants that will be licensed to grow medical marijuana in the state. "Half of the awardees already have existing businesses in Utah and the other half are out of state but have Utah ties. All grows will be located in Utah. Seven of the proposed sites are in rural areas and one is in an urban area," Kerry W. Gibson, commissioner of the Utah Department of Agriculture and Food, said in a statement. The agency could have awarded up to 10 licenses, but said it wanted to avoid an oversupply of product.

Obituaries

Criminal Justice and Drug Policy Expert Mark Kleiman Dead at 68. Longtime criminal justice and drug policy expert Mark Kleiman died Sunday of complications from a kidney transplant, his family reported. Coauthor with Jonathan Caulkins, Angela Hawken and Beau Kilmer of Marijuana Legalization: What Everyone Needs to Know, Kleiman rejected what he called a false dichotomy between legalization and prohibition, arguing for a middle ground that would end prohibition while avoiding the rise of commercially driven "Big Marijuana." His nuanced approach to drug and criminal justice reform didn't always sit well with reformers, but he was for decades a thoughtful and innovative scholar in the arena.

International

Brazil Removing Independents from Drug Policy Council. Rightist President Jair Bolsonaro is removing most non-governmental representatives from a council that sets policy on drugs. In a presidential decree Monday, he cut the size of the council in half and removed experts chosen by associations of jurists, physicians, social workers and other independent groups, leaving mostly those appointed by the government. Critics say it is a move designed to stifle dissent. It is also a continuation of an approach he has already applied to environmental and cultural affairs.

UNODC Warns of Rising Role of Organized Crime in Southeast Asia. In a report issued last Thursday, the UN Office on Drugs and Crime (UNODC) warned that transnational crime groups in the region are generating massive profits from the trafficking of drugs, people, and counterfeit goods, and are becoming increasingly aggressive. UNODC said the methamphetamine trade in particular had exploded, jumping in value from around $15 billion in 2013 to somewhere between $30 and $60 billion now.

Chronicle AM: NJ Legal Pot Deal Reached, Key UN Body Calls for Global Drug Decrim, More... (3/12/19)

Marijuana and medical marijuana bills are seeing action in the states, South Dakota's governor vetoes an industrial hemp bill, a key UN organization calls for global drug decriminalization, and more.

New Jersey Gov. Phil Murphy (D) says he has reached an agreement with key legislators to legalize weed by month's end. (CC)
Marijuana Policy

Colorado Bill to Allow Social Consumption Filed. State Rep. Jonathan Singer (D) and cosponsors filed House Bill 1230 last Friday. The bill would pave the way for legal marijuana “tasting rooms” beginning in January. The bill would also allow hotels, spas, and other businesses to apply for cannabis licenses. A similar bill was vetoed by Gov. John Hickenlooper last year, but now the governor is the more marijuana-friendly Jared Polis.

Minnesota Senate Committee Kills Legalization Bill. The Senate Judiciary Committee on Monday killed a bill that would have legalized marijuana on a 6-3 vote along party lines. SF 619 would have allowed adults to use, possess, grow, and buy marijuana from licensed retailers.

New Jersey Governor, Key Lawmakers Announce Agreement on Legalization Bill. Gov. Phil Murphy (D) and legislative leaders announced Tuesday that they had reached agreement on a bill to legalize marijuana. They also announced that they planned to pass the bill on March 25. "I believe that this legislation will establish an industry that brings fairness and economic opportunity to all of our communities while promoting public safety by ensuring a safe product and allowing law enforcement to focus their resources on serious crimes," the governor said.

New York Legalization Bid Hits Bump. Gov. Andrew Cuomo (D) said Monday that it is now unlikely that marijuana legalization will be included in the state budget, which is due this month, suggesting that there are roadblocks remaining on the path to legalization. "I’m no longer confident marijuana will be done in the budget," Cuomo told reporters at the Capitol, adding that legislative leaders are still far apart on a path forward. "I’ve had discussions with them on it. There is a wide divide on marijuana. I believe ultimately we can get there, and we must get there," he said. "I don’t believe we get there in two weeks. And also that’s what the legislative leaders have said."

Washington Senate Approves Expungement Bill. The Senate on Monday approved SB 5605, which would expunge some 69,000 past convictions for misdemeanor marijuana possession in the state. A companion measure is moving in the House.

Medical Marijuana

Earl Blumenauer Reintroduces Veterans Medical Marijuana Bill. Rep. Earl Blumenauer (D-OR) is back once again with a bill that would allow doctors at the Veterans Administration to recommend medical marijuana to veterans. HB 1647 is similar to bills that Blumenauer has sponsored for the past several years but were blocked by intransigent House Republican leaders. This year, though, the Democrats control the House.

Michigan Adds Cerebral Palsy to List of Qualifying Conditions. The Department of Licensing and Regulatory Affairs announced Monday that it had added cerebral palsy to the list of qualifying conditions to use medical marijuana. It rejected adding chronic aggressive behavior after panel members unanimously recommended denial.

New Mexico Medical Marijuana Access Expansion Bill Passes Senate. The Senate on Monday approved SB 406, which would allow for onsite consumption of medical marijuana at dispensaries, allow people living on Indian land to grow their own, and create civil protections for patients for schooling, child custody, and medical care. A similar bill was vetoed by Gov. Susana Martinez (R) last year, but she’s gone now.

Hemp

South Dakota Governor Vetoes Hemp Bill. Gov. Kristi Noem (R) on Monday vetoed HB 1191, which would have legalized industrial hemp production in the state. In her veto message, she said it could be a first step toward legalizing marijuana and that it could make law enforcement’s job more difficult. The bill passed the House overwhelmingly but passed the Senate by a margin just short of veto-proof. It’s not clear yet whether the legislature will attempt an override.

International

Key UN Organization Calls for Global Drug Decriminalization. The UN Chief Executives Board (CEB), representing 31 UN agencies including the Office on Drugs and Crime, had adopted a position calling on member states to adopt science-based, health-oriented approaches to drug policy—namely decriminalization. The policy shift came in January, but was not publicly announced.

Israel’s Netanyahu Says He’s Open to Marijuana Legalization. Faced with a party that advocates marijuana legalization gaining momentum in the weeks before national elections, Israeli Prime Minister Benjamin Netanyahu said Monday he was looking into legalizing it himself. Younger voters have been drifting toward support for the Zehut Party before the April 9 elections.

UN Reports Methamphetamine Production Skyrocketing in Southeast Asia. The UN Office on Drugs and Crime reported Monday that methamphetamine production in Southeast Asia is booming, with prices dropping and usage expanding even as seizures hit record highs. "Data on seizures, prices, use, and treatment all point to continuing expansion of the methamphetamine market in East and Southeast Asia," said Tun Nay Soe, the agency's inter-regional program coordinator. "The shift to methamphetamine has affected even countries traditionally known to have a relatively large market for heroin, such as China and Malaysia,” he added. “In Malaysia, the number of methamphetamine users detected by law enforcement authorities surpassed that of heroin users for the first time in 2017." 

The Year in Drugs I: The Top Domestic Drug Policy Stories of 2018 [FEATURE]

This is a year that just about everybody is eager to see come to an end, but when it comes to drug policy, 2018 hasn't been half-bad, at least in the US. (Check back next week for our Top International Drug Policy Stories.)

We've seen marijuana legalization spread further, we're on the verge of seeing Congress pass major sentencing reform legislation, and the ban on domestic hemp cultivation is coming to an end, among other things.

A lot went on in drug policy in 2018. Here are eight stories that helped define the year:

1. Overdose Deaths Remain Unconscionably High But Appear to Have Leveled Off

That's enough fentanyl to kill you. It killed thousands this year. (dea.gov)
The nation's fatal drug overdose crisis is far from over, but it now looks like it at least didn't get any worse this year. Driven in large part by the rise of fentanyl, overdose deaths reached a stunning 72,000 in 2017, a figure ten times the number in 1980 and double that of only a decade ago.

But preliminary reports on the 2018 overdose numbers suggest that this may be the year the crisis began to ease. In June, the Centers for Disease Control and Prevention released provisional data showing that overdose deaths had declined for six straight months, dropping 2.8 percent from their 2017 peak. That report also found that opioid overdose deaths had declined by 2.3 percent.

With both heroin and prescription opioid deaths declining, fentanyl has emerged as the most common drug involved in overdoses, being implicated in about a quarter of all drug overdose deaths. While the apparent decline in opioid overdose deaths this year is good news, the recent increases in cocaine and methamphetamine overdose deaths is not. And while any break in a years-long climb in overdose deaths is certainly welcome, another 70,000 or so Americans will still have died from them this year. We have a long, long way to go.

2. Safe Injection Sites Draw Nearer, But Feds Fire Warning Shots

Safe injection sites -- also known as supervised consumption sites, among other names -- where drug users can consume their doses under medical supervision and with an opportunity to engage with social services are a proven harm reduction intervention. More than a hundred cities around the world, mainly in Europe, Canada, and Australia have resorted to such facilities as a means of providing better outcomes, not only for drug users but also for the communities in which they live.

There are no legally permitted safe injection sites in the United States (although some underground ones are reportedly operating in Seattle, and there may be more in hiding), but this year saw mounting pressure and serious efforts to get them up and running in a number of American states and cities. It also saw mounting resistance from federal officials.

At the state level, California, Colorado, Missouri, and New York all saw safe injection site bills filed. Only the bill in California made it out of the legislature, but to the great frustration of reformers, it was vetoed by Gov. Jerry Brown (D), who cited long outdated beliefs about substance use in his veto message. Still, the fact that bills are being filed shows the issue is gaining momentum.

The momentum is even stronger among a handful of major cities. Denver, New York City, Philadelphia, and Seattle have all taken steps to clear the way for safe injection sites this year, although none are yet in place.

While like California's Gov. Brown, some state and local level political figures are hesitant to embrace them, a major reason none is yet in place is federal hostility. As the clamor for the facilities grows louder, so does opposition from the Trump administration. As Denver publicly pondered opening one, the local DEA and the US Attorney loudly warned they would be illegal, and the Philadelphia US Attorney did the same thing. Early in the year, the DEA in Washington issued a warning against safe injection sites, and in August, Deputy Attorney General Rod Rosenstein authored an op-ed in the New York Times issuing similar dire threats.

3. A Major Federal Sentencing Reform Bill Is Set to Pass

A rare example of bipartisanship on the Hill. (Creative Commons)
The first major federal sentencing reform bill in eight years is now one vote away from passing Congress. The bill, known as the First Step Act (S.3649), is the culmination of years of work by the likes of Senate Judiciary Committee Chairman Charles Grassley (R-IA) and Sen. Dick Durbin (D-IL), and includes prison reform language as well as provisions that would reduce sentences for certain drug offenses. It very nearly died earlier this month when Senate Majority Leader Mitch McConnell (R-KY) announced he would not bring it to a Senate floor vote, but under broad pressure, including from President Trump, McConnell relented, and the bill passed the Senate Tuesday

The sentencing reforms include retroactivity for the Fair Sentencing Act (the 2010 law that reduced the crack/powder cocaine sentencing disparity), allowing the potential release of around 2,600 people; expansion of the "safety valve" allowing judges more discretion to sentence beneath mandatory minimum sentences; reform of the "three strikes" law, reducing the "second strike" mandatory minimum of 20 years to 15 years, and reducing the "third strike" mandatory minimum of life-in-prison to 25 years.

The late word is that the bill will pass the House easily, but that hasn't happened as of this writing. If and when it does, the country will have taken a significant step toward a more just and humane federal criminal justice system. The passage has also drawn major media attention as a rare example of bipartisanship in Washington today.

4. Marijuana Legalization Advances in the States

At the beginning of the year, marijuana for adult recreational use was legal in eight states, all in the West or New England and all thanks to the initiative process. As 2018 comes to a close, that number has jumped to ten, with Vermont in January becoming the first state to legalize it through the legislature and Michigan in November becoming the first Midwest state to legalize it.

The initiative process is available in only half the states, and when it comes to legalizing weed, the low-hanging fruit has already been picked. A legalization initiative in conservative Nebraska went down to defeat this year, and remaining initiative states like the Dakotas, Nebraska, Oklahoma, and Arkansas are among the most socially conservative and least likely to free the weed. But prospects are rosier in initiative states Arizona, Missouri, and Ohio. We are likely to see pot on the ballot in all three in 2020.

Vermont remains the sole state to legalize it legislatively, but a handful of states edged ever closer close this year. New Jersey Gov. Phil Murphy (D) wanted pot legalized in his first 100 days. That didn't happen, and legalization hasn't gotten through the legislature yet, but there is a small chance it could still happen this year and a very good chance it will be a done deal by early next year. Legislatures throughout the Mid-Atlantic states and Northeast grappled with the issue, laying the groundwork for next year and the year beyond, and just this week, New York Gov. Andrew Cuomo (D) called for legalization next year. The long march continues.

5. Marijuana Is Still Federally Illegal, But the Crackdown Never Came

As the year comes to end, legal weed is still here and Jeff Sessions isn't. President Trump's first attorney general was an avowed foe of marijuana (as well as drug and criminal justice reform in general), but despite rescinding the Obama-era Cole memo, which basically told federal prosecutors to leave state law-abiding pot businesses alone, the much-feared crackdown on the industry never came.

Federal prosecutors, for the most part, continue to view legal marijuana businesses as a low priority, especially when faced with much more serious drug problems, such as the opioid overdose epidemic. But Sessions was also undercut by his own boss, who in April arranged a deal with Colorado Republican Sen. Cory Gardner in which he agreed to support a bill protecting states that have broken with federal pot prohibition in return for Gardner's allowing Justice department appointments to move forward.

This year saw a plethora of federal marijuana reform bills, but with Republican leadership in both houses firmly opposed, the Capitol was where marijuana reform went to die. With Democrats in control of the House next year, things promise to be different next year, although the GOP-led Senate will remain an obstacle. But with pot consistently polling in the 60s, those Republican senators may grudgingly start coming on board.

6. Marijuana Legalization is Nice, But We Need Social Justice, Too

This year saw social justice concerns around marijuana legalization move front and center in two distinct ways: demands for the expungement of marijuana arrest records for people whose offenses are no longer crimes and demands for restorative racial justice from communities that have suffered the brunt of the war on drugs.

The year started with two major West Coast cities, San Francisco and Seattle, leading the way on expungement. The, in September, California became the first state to put state-level automatic expungement into effect. Delaware and Rhode Island, which have both decriminalized but not legalized pot, also passed expungement bills this year. Expungement is also a contentious issue in the ongoing battle to get legalization passed in New Jersey.

After a half-dozen years of legalization and well-heeled white guys making bank off legal weed, the call for racial justice, whether in terms of set-asides to guarantee minority participation in the industry or for funding streams aimed at restoring drug war-ravaged communities, is growing too loud to be ignored. This is an ongoing struggle now being played out not only in pot-legal states, but especially in states on the cusp of legalization. Moving forward, it's likely that every successful state legalization bill is going to have to address issues of social and racial justice. As they should.

7. Industrial Hemp Becomes Federally Legal

The sun rises on the American domestic hemp industry. (votehemp.org)
Finally, the absolutely most ridiculous aspect of federal marijuana prohibition is dead. Recreational marijuana's country cousin, hemp can't get anyone high, but is extremely useful in a broad range of industries, from foods to textiles and beyond. Thanks to a lawsuit from hemp interests more than a decade ago, hemp could be imported for American firms to use in their products, but because the DEA refused to recognize any distinction between hemp and recreational marijuana, American farmers were forced to stand on the sidelines as their competitors in China, Canada, and other countries raked in the rewards.

But having a hemp-friendly senator from a hemp-friendly state allowed hemp legalization to move this year. Senate Majority Leader Mitch McConnell (R-KY) actually fought for the hemp bill, shepherding it into the must-pass farm appropriations bill and keeping it in there through negotiations with the House. President Trump has signed the farm bill, including the hemp provision, into law.

8. Here Come the 'Shrooms

Initiative campaigns to legalize or decriminalize the use and possession of psilocybin-containing magic mushrooms began popping up in 2018. Actually, the first state-level initiative came last year in California, but this past summer it failed to qualify for the fall ballot.

Right now, there are two psilocybin initiatives in the signature-gathering phase, a municipal initiative in Denver that would decriminalize the use, possession, and cultivation of psilocybin-containing mushrooms, and the statewide Oregon Psilocybin Service Initiative, which would decriminalize possession of psilocybin, allow magic mushrooms to be grown with a license, and would allow for therapeutic use of psilocybin. The Denver initiative would go before voters in May 2019, while the Oregon initiative aims at the 2020 election.

If psilocybin initiatives follow the pattern set by marijuana legalization initiatives, the first time may not be the charm. But more will follow.

What's Killing Us: The Ten Drugs Most Implicated in Overdose Deaths [FEATURE]

While there are signs that the country's drug overdose crisis may have plateaued, the number of people dying from drug overdoses continues to be unconscionably high. Shockingly, the number of overdose deaths has increased tenfold since 1980 when there were only 6,000 nationwide and nearly doubled just in the past decade to more than 72,000 last year.

The number of drug overdose deaths remains unconscionably high.
Now, in a new report, the Centers for Disease Control and Prevention (CDC) sheds some new light on precisely which drugs are most implicated in these deaths. While the report examines overdose deaths from 2011 to 2016, we're going to zero in on the 2016 data to get as close as possible to the present.

Three drug classes are involved: prescription and non-prescription opioids, benzodiazepines, and stimulants. Often, fatal overdoses involve more than one drug, whether it is drugs in the same class (heroin and fentanyl) or combinations of drug classes (heroin and benzos or fentanyl and cocaine.

Before we get into the number-crunching, it's worth taking a moment to consider that each single overdose death is a tragedy. A human life has been lost prematurely, the potential snuffed out, and friends and family members suffer greatly. It doesn't have to be that way. While we're going to look at deadly drugs, it behooves us to remember that many of these deaths are a function not just of the drugs themselves, but of drug prohibition.

People overdose on fentanyl, for example, because in a black market there is no packaging, no quality control, no dosage information to inform them of just how powerful is that powder they're snorting or injecting. Added to heroin or crafted into counterfeit prescription opioids by unscrupulous black market operators, fentanyl kills people who didn't even know they were taking it. Even more insidiously, fentanyl is turning up in black market cocaine and methamphetamine, whose users aren't even looking for an opioid high and haven't developed any tolerance to them (although some may be speedballing, that is, taking both an upper and a downer at the same time.

That said, here are the drugs making the greatest contributions to the 63,352 overdose deaths in 2016. (The numbers add up to more than that figure because in some overdoses, more than one drug is mentioned.)

1. Fentanyl -- 18,335

In 2016, fentanyl vaulted into first place in the deadly drug sweepstakes. As recently as 2011, the synthetic opioid was in 10th place, with some 1,660 overdose deaths attributed to it, but the death toll has increased more than tenfold in just five years. More than two-thirds of fentanyl overdose deaths also involved other drugs, and fentanyl is involved in more than a quarter (28.5 percent) of all overdose deaths, including 40 percent of cocaine overdose deaths and nearly a third (32 percent) of heroin deaths.

2. Heroin -- 15,961

At the tail end of the prescription opioid phase of the current overdose crisis in 2011, more people died from oxycodone than heroin, but between 2012 and 2015, heroin resumed its role as the leading opioid linked to fatal overdoses, only to be overtaken by fentanyl in 2016. The vast majority -- 70 percent -- of people who died from heroin were also using other drugs. More than a third were also using fentanyl, while nearly a quarter (23.8 percent) were also using cocaine. As prescription opioids became more difficult to obtain, the number of people dying from heroin skyrocketed, nearly tripling in the five years ending in 2016.

3. Cocaine -- 11,316

Cocaine deaths rose dramatically beginning in 2015 and by 2016 the annual death toll was double what it had been five years earlier. With bumper crops in Colombia in recent years, cocaine is cheap and plentiful. It is also increasingly being cut with fentanyl, which is implicated in 40 percent of cocaine deaths, and mixed with heroin, which is implicated in a third of them. Cocaine is named in 17.8 percent of all overdose deaths.

4. Methamphetamine -- 6,762

Meth-related overdose deaths tripled between 2011 and 2016, a dramatic increase in what has become America's forgotten drug problem. In 2016, slightly more than one out of ten drug overdose deaths involved meth. Of the top ten overdose drugs, meth is by far the one most likely to have been the sole drug implicated in the death, but even so, fentanyl was implicated in one out five meth deaths and heroin in one out of ten.

5. Alprazolam -- 6,209You know it as Xanax. This short-acting benzodiazepine is a favorite of stimulant users seeking to take the edge off, but also often forms part of a sedative cocktail with opioids or other benzos. About three-quarters of Xanax overdose deaths involve other drugs, with fentanyl, heroin, and oxycodone each involved in about one-quarter of Xanax deaths. Xanax deaths increased by about 50 percent over the five year period.

6. Oxycodone -- 6,199

It's most infamous formulation is OxyContin, but it is also sold as Roxicodone, Xtampza ER, and Oxaydo. It may have been the primary killer opioid a decade ago, but has chugged along at around 5,000 deaths a year before going over 6,000 in 2016. Four out of five people who overdose on oxycodone were also using another drug, most often Xanax (25.3 percent), followed by fentanyl (18.6 percent).

7. Morphine -- 5,014

The granddaddy of opioids. Morphine deaths increased slowly beginning in 2011, but have still increased by about 40 percent since then. More than eight out of 10 morphine deaths involve other drugs as well, particularly fentanyl, which is involved in one out three morphine deaths. Cocaine (16.9 percent) and heroin (13.7 percent) are also frequent contributors to morphine ODs.

8. Methadone -- 3,493

Prescribed as an opioid maintenance drug, methadone is one of the few drugs on this list to have seen the number of deaths decline between 2011 and 2016. They've dropped from more than 4,500 a year down to less than 3,500, a drop of roughly a quarter. Nearly three-fourths of all methadone deaths implicate other drugs, with Xanax being most common (21.5 percent), followed by fentanyl (15.1) and heroin (13.8).

9. Hydrocodone -- 3,199

This semi-synthetic opioid is sold under a variety of brand names, including Vicodin and Norco, and has proven remarkably stable in its overdose numbers. Between 2011 and 2016, it never killed fewer than 3,000 or more than 4,000, almost always (85 percent of the time) in concert with other drugs. Xanax was implicated in one-quarter of all hydrocodone overdoses, followed by oxycodone (17.2 percent) and fentanyl (14.9 percent).

10. Diazepam -- 2,022

The most well-known diazepam is Valium. Like Xanax, this anti-anxiety drug can be used to take the edge off a stimulant binge, but it's not coke heads and speed freaks who are dying from it. In more than nine out of 10 fatal Valium overdoses, other drugs are involved, most commonly the opioids oxycodone and fentanyl, each implicated in about a quarter of the deaths, and heroin, implicated in a fifth.

Using these drugs is dangerous. Using them under a prohibition regime is even more so. Users don't always know what they're getting, and that lack of knowledge can be fatal. If you're going to be messing with these substances, be extremely cautious. Try a test dose first. And don't do it alone. Stay safe out there.

This article was produced by Drug Reporter, a project of the Independent Media Institute.

Georgia Nightmare: Jailed Four Months for Possession of Cotton Candy [FEATURE]

A Georgia woman has filed a federal lawsuit after she spent nearly four months in jail because a roadside drug test administered by untrained police officers falsely identified a bag of cotton candy as methamphetamine.

Meth or cotton candy? Georgia cops couldn't tell the difference. (Creative Commons)
Monroe County resident Dasha Fincher filed the lawsuit in mid-November against Monroe County, the two deputies who arrested her, and the company that makes the drug test. The lawsuit argues that the Monroe County Sheriff's Office was reckless and negligent and violated her civil rights.

According to the lawsuit, the car Fincher was riding in was pulled over on New Year's Eve 2016 because of a dark window tint, the deputies said, even though they later admitted the windows were legal. Deputies Cody Maples and Allen Henderson spotted a large open plastic bag inside the vehicle, and Fincher explained that it was cotton candy.

The deputies didn't believe Fincher and used a roadside field drug test which they said indicated there was meth in the bag. She was then arrested, hauled off to jail, and charged with meth trafficking and possession of meth with intent to distribute. Her bond was set at $1 million, which she was unable to come up with, so she sat in jail for the next four months.

In March 2017, Georgia Bureau of Investigation lab test results revealed that the substance was not an illegal drug, but Fincher sat in jail for another month before prosecutors finally dropped the charges.

The lawsuit says the drug test is the Nark II, manufactured by North Carolina-based Sirchie Acquisitions. That particular field drug test is known for producing errant results. In Georgia alone, police using the Nark II to field test drugs have wrongfully arrested at least 30 people, including a man with breath mints (positive for crack), a teacher with Goody's Headache Powder (positive for cocaine), and a couple with vitamins (positive for ecstasy).

In all those cases, as in Fincher's, lab test results from the Bureau of Investigation found no presence of illegal substances. But in all those cases, the exonerating results came only weeks or months later, after the harm to innocent Georgians had already been done.

The Nark II is still in wide use in Georgia. The manufacturer, Sirchie, defends itself by saying: "Our NARK presumptive drug tests are presumptive only. All samples should be sent to a crime lab for confirmation." But too many Georgia law enforcement agencies clearly don't bother to wait for confirmation before making life-changing arrests. And the state of Georgia doesn't even require police officers to be trained on how to do the tests. As a result, innocent Georgians are being wrongfully arrested and jailed. And now, perhaps, at least one of these law enforcement agencies, will have to pay for its wrongdoing.

This article was produced by Drug Reporter, a project of the Independent Media Institute.

How This Red State's Cruel Meth Laws Are Putting Women Behind Bars in Record Numbers [FEATURE]

Like other Great Plains states, South Dakota has a methamphetamine problem. But it's becoming increasingly evident that South Dakota also has a problem with the way it deals with meth.

South Dakota women's prison in Pierre (KELO-TV screen grab)
Because of its strict drug laws, the state is seeing a dramatic spike in women being sent to prison for meth. According to a new report from the nonprofit South Dakota News Watch, the number of women in prison in the state has jumped 35 percent since 2013, while the male prison population has increased at only one-quarter of that rate. Nearly two-thirds of all women prisoners in the state are there for nonviolent drug offenses. The state now has the fourth-highest incarceration rate for women in the country, trailing only Oklahoma, Wyoming, and Kentucky.

Overall, about one-third of all inmates in the state are doing time for drug-related offenses, the majority of them for simple drug possession. That's a higher percentage than most other states, where drug offenders tend to make up somewhere around 20 to 25 percent of the inmate population.

The high drug-related incarceration overall and for women in particular stems less from the prevalence of drug use than from the conservative, largely rural state's reaction to it. South Dakota has not responded to decades of failed war on drug policies by reforming them, but by doubling down on them.

The state has not moved toward the defelonization of drug possession, as at least 16 others have. Instead, it has moved in the opposite direction. South Dakota has mandatory sentencing laws that include prison for not only for the manufacture and distribution of meth but also for simple possession.

State lawmakers and cops have long favored tough drug laws, and they are still at it. This year, state Attorney General Marty Jackley (R) guided bills through the legislature that heighten penalties for meth dealing and increase sentences for dealers whose clients overdose and die.

But the state's most notorious and contentious drug law -- bone that is sending hundreds of people to prison -- is the state's "possession by ingestion" statute. Otherwise known as an "internal possession" law, the statute allows for a felony conviction if a drug test reveals the presence of illicit drugs in a suspect's system. (The law also applies to marijuana, but the penalty for testing positive for pot is only a misdemeanor.)

The strictest in the nation, that law was upheld by the state Supreme Court in 2004. Last year, a bipartisan group of lawmakers filed a measure that would have slightly tweaked the law by removing marijuana, but that bill was killed by a unanimous vote in the first committee that heard it.

As of August, about nine percent of the male prison population and an astonishing 21 percent of the female prison population was doing time for unauthorized ingestion of a controlled substance. That's right: More than one out of five women prisoners in South Dakota is behind prison bars for nothing more than having used drugs.

South Dakota law enforcement and lawmakers may be happy with the status quo, but the man who actually runs the prison system isn't. State Corrections Secretary Denny Kaemingk told South Dakota News Watch that the cops' and courts' proclivity for busting and imprisoning women on drug charges is creating an expensive and ineffective cycle of imprisonment, release, and recidivism.

"We seem to think that locking individuals up is going to solve their addiction problem," said Kaemingk, a former drug officer. "They're coming to us in corrections and we're thinking that solves the problem, and I think in many cases it makes the problem worse."

Criminalizing addiction, especially among women who are mothers, Kraemingk said, creates a situation where the children are more likely to end up in prison themselves. He pointed to national studies showing that up to 80 percent of children who have parents behind bars will end up there themselves.

"Imprisonment in South Dakota is generational," Kaemingk said. "The females behind prison walls have experienced that as a child. The generation we have back there now as inmates experienced the same things when they were children."

Kraemingk and other relatively enlightened actors in the state are pushing for enhanced treatment opportunities and expanding drug courts, among other measures, to better deal with the situation, but nobody seems to be talking about not involving these women in the criminal justice system in the first place. A first step would be getting rid of that hideous "possession by ingestion" statute. The next step would be defelonization or outright decriminalization of drug possession in the state. Drug use absent harm to others should not be the state's business.

This article was produced by Drug Reporter, a project of the Independent Media Institute.

Chronicle AM: Feinstein Cosponsors STATES Act, US Will Bar Canadian Pot People from Entry, More... (9/14/18)

Medical professionals are on board with marijuana legalization, and Diane Feinstein is getting there, too; the latest national drug use survey is out, US Customs talks tough about Canadians and marijuana, and more.

Sen. Dianne Feinstein is coming around on marijuana policy. (senate.gov)
Marijuana Policy

Dianne Feinstein Signs On as Cosponsor of STATES Act. The STATES Act (S 3032) has picked up a somewhat surprising 10th cosponsor: Sen. Dianne Feinstein (D-CA). The bill, introduced by Sens. Cory Booker (D-NJ) and Elizabeth Warren (D-MA), would allow states that have legalized either medical or recreational marijuana to do so without federal interference. Feinstein has long been a foe of marijuana legalization, but she has been changing her tune lately, and this is the latest example of her shifting stance.

Poll Finds Medical Professionals Support Marijuana Legalization. A poll of medical professionals conducted by Medscape Medical News found majority support for marijuana legalization among doctors (54%), health administrators (72%), nurses (57%), pharmacists (54%), and psychologists (61%). Support was even higher for medical marijuana, with two-thirds (67%) of physicians and more than 80% among all other groups except pharmacists, who came in at 71%.

Medical Marijuana

Michigan Judge Issues Injunction to Keep A Hundred Dispensaries Open. Court of Claims Judge Stephen Borrello on Thursday granted an injunction that blocks the state from shutting down some 98 dispensaries until they are approved for state licenses. These are dispensaries that are in the midst of applying for licenses. They will now get to stay open until December 15.

Drug Policy

National Drug Use Survey Finds Drop in New Heroin Users, But Meth, Marijuana Use Up. The 2017 National Survey on Drug Use and Health was released Friday. Among the significant findings: The initiation of heroin use is down dramatically, fewer young people are misusing prescription opioids (down from 8.5% to 7%), but more people are using marijuana and methamphetamine. 

US Customs Official Warns Canadians Who Smoke Legal Marijuana or Work or Invest in the Industry Will Be Banned from Entering US. US Customs and Border Patrol official Todd Owen said Thursday that any Canadians who admit to having used marijuana, work for the country's legal pot industry, or invest in it will be barred from entering the United States. Canadian legalization goes into effect October 17, but Own said the US doesn't plan to change its border policies because of that. "We don't recognize that as a legal business," Owen said. 

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, Vaping, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safer Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psilocybin / Magic Mushrooms, Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School